home / stock / hbpcf / hbpcf news

HBPCF News and Press, Helix Biopharma Corp From 11/01/22

Stock Information
Company Name: Helix Biopharma Corp
Stock Symbol: HBPCF
Market: OTC
Website: helixbiopharma.com
Menu
HBPCF HBPCF Quote HBPCF Short HBPCF News HBPCF Articles HBPCF Message Board
Get HBPCF Alerts

News, Short Squeeze, Breakout and More Instantly...
HBPCF - HELIX BIOPHARMA CORP. Announces Fiscal 2022 Year-End Results

--News Direct-- Toronto, Ontario – TheNewswire – November 1, 2022 - Helix BioPharma Corp. (TSX:HBP), (“Helix” or the “Company”), a clinical-stage biopharmaceutical company developing unique therapies in the field of immuno-oncology based on ...
HBPCF - Helix BioPharma Corp. Appoints Dr. Frank Gary Renshaw as Chief Medical Officer

--News Direct-- October 3, 2022 – TheNewswire - Toronto, Ontario – Helix BioPharma Corp. (TSX:HBP) (OTC:HBPCF) (“Helix” or the “Company”), a clinical-stage biopharmaceutical company that is developing unique therapies in the field of immuno-onco...

HBPCF - Helix BioPharma appoints R&D head

Helix BioPharma ( OTCPK:HBPCF ) appointed Gabrielle Siegers, as the head of R&D based out of the company's lab in Edmonton. Siegers joins comes to Helix from IN8bio, where she served as senior scientist/Gamma Delta T cell specialist, the Canadian biotech said in a...

HBPCF - Helix Biopharma Corp. Appoints Gabrielle M Siegers as the Head of Research & Development

--News Direct-- Toronto, Ontario – TheNewswire – September 1, 2022 – Helix BioPharma Corp. (TSX:HBP) (“Helix” or the “Company”), a clinical-stage biopharmaceutical company that is developing unique therapies in the field of immuno-oncolog...
HBPCF - Helix Biopharma Corp. Announces Conclusion of Funding Agreement with Lind Global Macro Fund LP

--News Direct-- Toronto, Ontario – TheNewswire – August 30, 2022 – Helix BioPharma Corp. (TSX:HBP) (“Helix” or the “Company”), a clinical-stage biopharmaceutical company that is developing unique therapies in the field of immuno-oncology ...

HBPCF - Helix BioPharma Corp. Announces Scientific Collaboration with University Hospital Tuebingen

--News Direct-- Toronto, Ontario – TheNewswire – August 9, 2022 – Helix BioPharma Corp. (TSX:HBP) (OTC:HBPCF) (“Helix” or the “Company”), a clinical-stage biopharmaceutical company that is developing unique therapies in the field of immun...

Previous 10 Next 10